Medscape

Use of Granulocyte Colony-stimulating Factor in Patients with Severe Sepsis or Septic Shock

Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...
Medscape

Clinical Applications of Colony-Stimulating Factors: A Historical Perspective

Outcomes measured to evaluate CSF efficacy include the incidence of febrile neutropenia, neutrophil recovery time, resource utilization (e.g., hospitalization rates, antimicrobial therapies, and ...
ascopubs.org

Pattern of granulocyte colony stimulating growth factors (G-CSGF) usage in patients treated with sacituzumab govitecan: A real world multicenter study using the TriNetX database.

Assessment of weight change and BMI as prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in a Polish female cohort. A phase I/II study evaluating the safety and ...
ascopubs.org

Patient characteristics associated with primary prophylactic granulocyte colony-stimulating factor (G-CSF) use among women treated for early-stage breast cancer.

Optimization of surgical management of the axilla since MonarchE trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.